Why Pfizer and BioNTech Shot Higher on Friday
The two companies stand an excellent chance of winning expanded authorization in Europe for their coronavirus vaccine.
Full Article
Why Pfizer and BioNTech Shot Higher on Friday
Motley Fool
0 shares
1 views
You might like
Related news coverage
Pfizer, BioNTech seek EU's OK to use COVID vaccine on kids
SeattlePI.com
LONDON (AP) — Pfizer Inc. and BioNTech have submitted a request to the European drug regulator for the approval of their..
-
North Macedonia looks to Chinese vaccine to revive program
SeattlePI.com
-
FTSE 100 firmly in the red; Wall Street opens on a mixed footing
Proactive Investors
-
FTSE 100 firmly in the red; COVID-19 infections fall significantly after single dose vaccines are rolled out, study shows
Proactive Investors
-
S&P/ASX 200 slips as miners drag
Proactive Investors